These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 5055688

  • 1. Preclinical pharmacologic studies on 1-nitro-9-(dimethylaminopropylamino)-acridine and its n-oxide. II. Chronic action.
    Gieldanowski J, Patkowski J, Szaga B, Teodorczyk J.
    Arch Immunol Ther Exp (Warsz); 1972; 20(3):419-44. PubMed ID: 5055688
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacological studies on new oncostatic acridine derivatives. II. Chronic action.
    Błaszczyk B, Giełdanowski J, Patkowski J, Kowalczyk-Bronisz SH.
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):765-76. PubMed ID: 549531
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preclinical pharmacologic studies on 1-nitro-9-(dimethylamino)-acridine and 1-nitro-10-(dimethylaminoethyl)-9-acridone. I. Acute and subacute action.
    Pelczarska A, Kowalczyk-Bronisz SH, Blaszczyk B, Gieldanowski J, Patkowski J.
    Arch Immunol Ther Exp (Warsz); 1974; 22(6):823-42. PubMed ID: 4451445
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological studies on new oncostatic acridine derivatives. I. Acute and subchronic action.
    Błaszczyk B, Giełdanowski J, Patkowski J, Kowalczyk-Bronisz SH.
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):749-63. PubMed ID: 549530
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Determination of average hematological values in the population of Forli].
    Ornigotti L.
    Quad Sclavo Diagn; 1973 Jun; 9(2):698-70. PubMed ID: 4789474
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Studies of pharmacological activity several acridine derivatives with cytostatic and oncostatic properties.
    Gieldanowski J.
    Mater Med Pol; 1976 Jun; 8(3):252-7. PubMed ID: 1034858
    [No Abstract] [Full Text] [Related]

  • 20. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
    Lee HH, Wilson WR, Ferry DM, van Zijl P, Pullen SM, Denny WA.
    J Med Chem; 1996 Jun 21; 39(13):2508-17. PubMed ID: 8691448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.